Showing 81 - 100 results of 1,303 for search 'Eligible (novel)', query time: 0.13s Refine Results
  1. 81

    Cross-sectional observational study of the availability of evidence supporting novel implantable devices used in gastrointestinal surgery. by Chapman, S, Shelton, B, Maruthappu, M, Singh, P, McCulloch, P, Bhangu, A

    Published 2017
    “… <h4>Background</h4> <p>Evidence supporting the implementation of novel surgical devices is unstandardized, despite recommendations for assessing novel innovations. …”
    Journal article
  2. 82
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87

    A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Diffuse Large B Cell Lymphoma by Wang Z, Bao Y, Xu Z, Sun Y, Yan X, Sheng L, Ouyang G

    Published 2024-01-01
    “…Eligible patients were randomly divided into training and validation cohorts (n = 281 and 71, respectively) in an 8:2 ratio. …”
    Get full text
    Article
  8. 88

    Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression by Natasja Franceschini, Jan Oosting, Maud Tamsma, Bertine Niessen, Inge Briaire-de Bruijn, Brendy van den Akker, Alwine B. Kruisselbrink, Ieva Palubeckaitė, Judith V. M. G. Bovée, Anne-Marie Cleton-Jansen

    Published 2021-06-01
    “…These results suggest that targeting NAMPT in osteosarcoma could be considered as a novel therapeutic strategy, where low NAPRT expression can serve as a biomarker for the selection of eligible patients.…”
    Get full text
    Article
  9. 89
  10. 90

    Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes by Sarah Jungius, Sarah Jungius, Franziska C. Adam, Kerstin Grosheintz, Michael Medinger, Andreas Buser, Jakob R. Passweg, Jörg P. Halter, Sara C. Meyer, Sara C. Meyer, Sara C. Meyer, Sara C. Meyer

    Published 2023-08-01
    “…Allogeneic hematopoietic cell transplantation (HCT) represents a potentially curative therapy for a limited subset of patients with advanced MF, who are eligible, but engraftment in MF vs. AML is delayed which promotes complications. …”
    Get full text
    Article
  11. 91
  12. 92
  13. 93

    A Novel MADM Framework under <i>q</i>-Rung Orthopair Fuzzy Bipolar Soft Sets by Ghous Ali, Hanan Alolaiyan, Dragan Pamučar, Muhammad Asif, Nimra Lateef

    Published 2021-09-01
    “…In this research study, a novel hybrid model under the name of <i>q</i>-rung orthopair fuzzy bipolar soft set (<i>q</i>-ROFBSS, henceforth), an efficient bipolar soft generalization of <i>q</i>-rung orthopair fuzzy set model, is introduced and illustrated by an example. …”
    Get full text
    Article
  14. 94
  15. 95
  16. 96
  17. 97
  18. 98

    Novel Theranostic Approaches Targeting CCR4-Receptor, Current Status and Translational Prospectives: A Systematic Review by Joana Gorica, Maria Silvia De Feo, Ferdinando Corica, Marko Magdi Abdou Sidrak, Miriam Conte, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi

    Published 2023-02-01
    “…Background: With the high mortality rate of malignant tumors, there is a need to find novel theranostic approaches to provide an early diagnosis and targeted therapy. …”
    Get full text
    Article
  19. 99
  20. 100

    Generation of Mouse Model of Hemophilia A by Introducing Novel Mutations, Using CRISPR/Nickase Gene Targeting System by Mehdi Shamsara, Abbas Jamshidizad, Aidin Rahim-Tayefeh, Maliheh Davari, Ali Rajabi Zangi, Fatemeh Masoumi, Alireza Zomorodipour

    Published 2023-09-01
    “…The CRISPR/nickase system was successfully applied to generate mouselines with the knockout fviii gene. The two novel FVIIIKO mice demonstrated all clinical symptoms of hemophilia A, whichcould be successfully inherited. …”
    Get full text
    Article